Meclizine Hydrochloride Tablets — Class II drug recall D-0418-2026
Ongoing recall by Amerisource Health Services LLC, reported 2026-04-01, distributed nationwide. Failed tablet specifications.
| Recall number | D-0418-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Amerisource Health Services LLC, Columbus, OH, United States |
| Recall initiated | 2026-03-16 |
| Classified | 2026-03-31 |
| Reported by FDA | 2026-04-01 |
| Distributed | Nationwide (US) |
| Quantity | 697 cartons |
| NDC | 60687-0730, 60687-0730-01, 60687-0730-11, 60687-0730-65, 60687-0775, 60687-0775-01, 60687-0775-11, 60687-0775-65 |
| Lot numbers | 1024852 |
| Expiration dates | 2026-09-30 |
Product
Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.
Reason for recall
Failed tablet specifications.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0418-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.